ADVERTISEMENT
Search

Pharmacy News

Race, socioeconomic status associated with lower SGLT2 inhibitor use

If you are wondering what health care disparities might look like in medication use for chronic diseases, a new study published in JAMA Network Open can serve as just one example. Among patients with diabetes in the United States, researchers found that lower rates of SGLT2 inhibitor use, a medication with substantial cardioprotective and kidney protective benefits, is associated with Black race, Asian race, female gender, and lower household income.

RSS
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT